Mereo BioPharma Group PLC ADR
MREO
$0.35-0.31%
Delayed · as of Oct 7, 2026, 2:00 PM ET
Mkt cap
$48.68M
EV/Sales
15.4
P/E ratio
N/A
FY2025 Revenue
$500,000
EPS (TTM)
$-0.04
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-8375.60%
Beta
0.19
Div yield
N/A
Sector
Healthcare
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported MREO revenue for 2025-12-31 was $500.0K. Net income was -$41.9M. MREO currently screens at market cap $48.7M.
Use this MREO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MREO income, balance, and cash tables.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company in the Healthcare sector.
Latest cached Mereo BioPharma Group PLC ADR (MREO) revenue for Dec 31, 2025 was $500.0K. Net income was -$41.9M. Statements: https://lician.com/financials/mreo
Mereo BioPharma Group PLC ADR (MREO) market capitalization is $48.7M on the latest cached snapshot.
Mereo BioPharma Group PLC ADR (MREO) cached previous close $0.35; day range $0.35 – $0.37; volume 471,981. Session quote: https://lician.com/quote/mreo
Mereo BioPharma Group PLC ADR (MREO) latest cached earnings event is "MREO earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MREO filing is 8-K · Aug 19, 2026. Filings: https://lician.com/sec/mreo